Benefits
Non-hormonal muscle protein synthesis support
Laxogenin is proposed to stimulate muscle protein synthesis through a brassinosteroid-analogous mechanism — activating protein synthesis signaling in muscle cells without engaging androgen receptors. The non-hormonal mechanism is its primary appeal for athletes in tested sports and those avoiding hormonal ingredients.
Anabolic support without testosterone effects
Unlike prohormones, SARMs, or anabolic steroids, laxogenin does not appear to affect testosterone, DHT, estrogen, LH, or FSH levels in preliminary studies — making it a legal, over-the-counter muscle-building option for natural athletes seeking stacking with other anabolic ingredients without hormonal disruption.
Cortisol inhibition and anti-catabolic effects
Some evidence suggests laxogenin may inhibit cortisol-mediated protein catabolism in muscle tissue — providing anti-catabolic protection during intense training or caloric restriction, complementing any direct anabolic MPS stimulation.
Mechanism of action
Brassinosteroid-analogous protein synthesis stimulation
Laxogenin's spirostanol steroidal structure is proposed to mimic brassinosteroids — plant steroid hormones that activate protein synthesis in plant cells through BES1/BZR1 transcription factor pathways. In animal models, brassinosteroid administration increases skeletal muscle mass through pathways that may parallel animal steroid signaling without engaging androgen receptors. The specific molecular target in human muscle cells remains incompletely characterized, reflecting the limited human research base for this ingredient.
Clinical trials
Laxogenin (5α-Hydroxy-Laxogenin) has NO published peer-reviewed human clinical trials in PubMed as of 2025. Evidence base consists of in vitro studies, animal data, and supplier marketing. The cited URL is a manufacturer-affiliated marketing/blog page — not peer-reviewed clinical literature.
IN vitro only — Two cell-based bioassays: (1) yeast androgen screen (no activity observed); (2) human PC3(AR) prostate cells with luciferase reporter (dose-dependent androgen receptor transactivation, biphasic response). Not a human or animal in-vivo study. NO human clinical trial exists for laxogenin or 5α-hydroxy-laxogenin in PubMed as of May 2026.
Critical regulatory caveat: 5α-hydroxy-laxogenin is on the **DoD Prohibited Dietary Supplement Ingredients list** for U.S. military service members. Per OPSS (Operation Supplement Safety), "No studies have been done on the effects of laxogenin or 5-alpha-hydroxy-laxogenin in humans or animals, including whether these ingredients can produce any of the effects claimed for them as dietary supplement ingredients to gain any muscle mass." showed in PC3(AR) cells a biphasic androgen receptor response: antagonistic at lower concentrations, agonistic at higher concentrations. Not FDA-approved for any use. Marketing claims of "natural anabolic" muscle-building benefits are entirely unvalidated in any human or animal study. Evidence-level should remain 1 (lowest). Strong recommendation against use in dietary supplements without further safety/efficacy data.